Lichen Planus, Oral
Oral lesions accompanying cutaneous lichen planus or often occurring alone. The buccal mucosa, lips, gingivae, floor of the mouth, and palate are usually affected (in a descending order of frequency). Typically, oral lesions consist of radiating white or gray, velvety, threadlike lines, arranged in a reticular pattern, at the intersection of which there may be minute, white, elevated dots or streaks (Wickham's striae). (Jablonski, Illustrated Dictionary of Dentistry)
Drugs by status
Phase 4 trials (17)
Phase 3 trials (10)
Phase 2 trials (13)
Phase 1 trials (7)
Other trials (20)
- fluocinonide
- benzocaine
- efalizumab
- nystatin
- qingxuan
- hyaluronic acid
- bifidobacterium infantis
- bifidobacterium breve
- bifidobacterium longum
- lactobacillus plantarum
- vsl #3
- streptococcus salivarius
- zinc dichloride
- paeony glucosides
- fluocinolone acetonide
- zinc sulfate
- Lactobacillus acidophilus
- lactobacillus casei
- lactobacillus reuteri
- lactobacillus delbrueckii
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (23)
- Celgene
- Novartis
- National Institutes of Health (NIH)
- National Institute of Dental and Craniofacial Research (NIDCR)
- Harvard University
- Mashhad University of Medical Sciences
- October 6 University
- Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
- University of Florida
- University of Peradeniya
- University of Toronto
- University of Zagreb
- College of Dental Sciences, India
- Qazvin University Of Medical Sciences
- University of California, San Francisco
- University of Utah
- Proinnovera GmbH
- Isfahan University
- University of Sao Paulo
- College of Dental Sciences, Davangere
- X-act Cologne Clinical Research GmbH
- Government of Croatia
- AFYX
Organization Involved with Phase 1 Indications (1)
Organization Involved with Other Experimental Indications (8)